$INTA
Intapp Inc Stock $inta

$inta Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000095017023047051 Filed on September 07, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$101.6M	$94.62M	$350.9M
YoY Change	27.71%	25.29%	28.96%
Cost Of Revenue	$31.57M	$30.85M	$111.5M
YoY Change	24.63%	13.62%	12.49%
Gross Profit	$70.00M	$63.77M	$239.4M
YoY Change	29.15%	31.84%	38.4%
Gross Profit Margin	68.92%	67.39%	68.23%
Selling, General & Admin	$55.47M	$50.71M	$213.2M
YoY Change	7.25%	-1.66%	7.67%
% of Gross Profit	79.24%	79.52%	89.06%
Research & Development	$28.50M	$25.50M	$93.85M
YoY Change	44.8%	29.89%	26.12%
% of Gross Profit	40.71%	39.99%	39.2%
Depreciation & Amortization	$4.009M	$3.913M	$15.32M
YoY Change	-2.6%	-7.54%	-8.5%
% of Gross Profit	5.73%	6.14%	6.4%
Operating Expenses	$83.97M	$76.21M	$308.7M
YoY Change	14.47%	7.04%	13.3%
Operating Profit	-$13.97M	-$12.44M	-$69.26M
YoY Change	-27.06%	-45.5%	-30.36%
Interest Expense	$39.00K	-$39.00K	$156.0K
YoY Change	0.0%	2.63%	-43.07%
% of Operating Profit
Other Income/Expense, Net	-$904.0K	$216.0K	-$503.0K
YoY Change	32.16%	-118.56%	-48.46%
Pretax Income	-$14.91M	-$12.27M	-$69.92M
YoY Change	-24.97%	-48.96%	-32.19%
Income Tax	$413.0K	-$795.0K	-$495.0K
% Of Pretax Income
Net Earnings	-$15.32M	-$11.47M	-$69.43M
YoY Change	-23.6%	-46.87%	-30.35%
Net Earnings / Revenue	-15.08%	-12.12%	-19.79%
Basic Earnings Per Share	-$0.22		-$1.08
Diluted Earnings Per Share	-$0.22	-$0.17	-$1.08
COMMON SHARES
Basic Shares Outstanding	69.24M	65.40M	64.30M
Diluted Shares Outstanding	68.94M		64.30M

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$141.5M	$130.4M	$130.4M
YoY Change	250.9%	156.73%	156.73%
Cash & Equivalents	$141.5M	$130.4M	$130.4M
Short-Term Investments
Other Short-Term Assets	$21.30M	$19.95M	$19.95M
YoY Change	-7.65%	1.27%	1.27%
Inventory
Prepaid Expenses	$8.972M	$7.335M
Receivables	$68.82M	$92.97M	$103.6M
Other Receivables	$500.0K	$878.0K	$878.0K
Total Short-Term Assets	$246.7M	$254.8M	$254.8M
YoY Change	95.88%	72.9%	72.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.70M	$16.37M	$33.55M
YoY Change	25.93%	33.24%	173.11%
Goodwill	$278.6M	$278.9M
YoY Change	3.48%	3.64%
Intangibles	$40.55M	$43.26M
YoY Change	-10.58%	-10.68%
Long-Term Investments
YoY Change
Other Assets	$1.818M	$1.846M	$18.38M
YoY Change	-28.43%	-24.68%	6.79%
Total Long-Term Assets	$370.9M	$374.1M	$374.1M
YoY Change	2.07%	7.79%	7.79%
TOTAL ASSETS
Total Short-Term Assets	$246.7M	$254.8M	$254.8M
Total Long-Term Assets	$370.9M	$374.1M	$374.1M
Total Assets	$617.6M	$628.9M	$628.9M
YoY Change	26.22%	27.2%	27.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.185M	$6.018M	$6.018M
YoY Change	36.26%	42.61%	42.61%
Accrued Expenses	$13.37M	$11.63M	$51.39M
YoY Change	75.93%	32.51%	5.35%
Deferred Revenue	$191.4M	$191.0M
YoY Change	26.55%	33.81%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$244.1M	$259.3M	$259.3M
YoY Change	15.35%	16.03%	16.03%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$9.325M	$9.378M	$26.93M
YoY Change	23.27%	-8.07%	108.53%
Total Long-Term Liabilities	$9.325M	$9.378M	$26.93M
YoY Change	23.27%	-8.07%	108.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$244.1M	$259.3M	$259.3M
Total Long-Term Liabilities	$9.325M	$9.378M	$26.93M
Total Liabilities	$270.9M	$287.7M	$287.7M
YoY Change	13.42%	20.61%	20.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$470.5M	-$455.2M
YoY Change	15.94%	18.0%
Common Stock	$69.00K	$69.00K
YoY Change	9.52%	9.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$346.7M	$341.2M	$341.2M
YoY Change
Total Liabilities & Shareholders Equity	$617.6M	$628.9M	$628.9M
YoY Change	26.22%	27.2%	27.2%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$15.32M	-$11.47M	-$69.43M
YoY Change	-23.6%	-46.87%	-30.35%
Depreciation, Depletion And Amortization	$4.009M	$3.913M	$15.32M
YoY Change	-2.6%	-7.54%	-8.5%
Cash From Operating Activities	$11.61M	$10.65M	$27.49M
YoY Change	261.18%	10.21%	93.08%
INVESTING ACTIVITIES
Capital Expenditures	$1.141M	$1.806M	$2.212M
YoY Change	-31.59%	-224.21%	299.28%
Acquisitions	$0.00		$6.604M
YoY Change			164.16%
Other Investing Activities		-$6.104M	-$6.604M
YoY Change		144.16%	164.16%
Cash From Investing Activities	-$3.002M	-$7.910M	-$14.34M
YoY Change	2.32%	100.05%	96.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.691M	74.43M	64.10M
YoY Change	-117.31%	2159.47%	864.34%
NET CHANGE
Cash From Operating Activities	11.61M	10.65M	27.49M
Cash From Investing Activities	-3.002M	-7.910M	-14.34M
Cash From Financing Activities	1.691M	74.43M	64.10M
Net Change In Cash	10.56M	77.17M	76.87M
YoY Change	-200.99%	756.87%	498.33%
FREE CASH FLOW
Cash From Operating Activities	$11.61M	$10.65M	$27.49M
Capital Expenditures	$1.141M	$1.806M	$2.212M
Free Cash Flow	$10.47M	$8.847M	$25.28M
YoY Change	576.86%	-20.44%	84.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001565687
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2023	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2024-08-31
CY2023Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40550
CY2023	dei	Entity Registrant Name EntityRegistrantName	Intapp, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-1467620
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3101 Park Blvd
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Palo Alto
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94306
CY2023	dei	City Area Code CityAreaCode	650
CY2023	dei	Local Phone Number LocalPhoneNumber	852-0400
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023	dei	Trading Symbol TradingSymbol	INTA
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	401100000
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	69240659
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	San Jose, California
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	130377000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50783000
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	808000
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	3528000
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	994000
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	918000
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	92973000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	66947000
CY2023Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	10661000
CY2022Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	6763000
CY2023Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	878000
CY2022Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3199000
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7335000
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5984000
CY2023Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	11807000
CY2022Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	10187000
CY2023Q2	us-gaap	Assets Current AssetsCurrent	254839000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	147391000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16366000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12283000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17180000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0
CY2023Q2	us-gaap	Goodwill Goodwill	278890000
CY2022Q2	us-gaap	Goodwill Goodwill	269103000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	43257000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	48430000
CY2023Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	16529000
CY2022Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	14755000
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1846000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2451000
CY2023Q2	us-gaap	Assets Assets	628907000
CY2022Q2	us-gaap	Assets Assets	494413000
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6018000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4220000
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39761000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	40004000
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11626000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8774000
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	191042000
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	142768000
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10902000
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	27753000
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	259349000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	223519000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1422000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2099000
CY2023Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1355000
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2712000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16195000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9378000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10201000
CY2023Q2	us-gaap	Liabilities Liabilities	287699000
CY2022Q2	us-gaap	Liabilities Liabilities	238531000
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68574000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68574000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62739000
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62739000
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	69000
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	63000
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	797639000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	643227000
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1339000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1672000
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-455161000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-385736000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	341208000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	255882000
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	628907000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	494413000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	350873000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	272071000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	214633000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	111462000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	99083000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	74374000
CY2023	us-gaap	Gross Profit GrossProfit	239411000
CY2022	us-gaap	Gross Profit GrossProfit	172988000
CY2021	us-gaap	Gross Profit GrossProfit	140259000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	93851000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	74412000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50853000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	132189000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	111905000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	69948000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	81031000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	86127000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42418000
CY2023	inta	Lease Modification And Impairment LeaseModificationAndImpairment	1601000
CY2022	inta	Lease Modification And Impairment LeaseModificationAndImpairment	0
CY2021	inta	Lease Modification And Impairment LeaseModificationAndImpairment	0
CY2023	us-gaap	Operating Expenses OperatingExpenses	308672000
CY2022	us-gaap	Operating Expenses OperatingExpenses	272444000
CY2021	us-gaap	Operating Expenses OperatingExpenses	163219000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-69261000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-99456000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-22960000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2407000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2023	us-gaap	Interest Expense InterestExpense	156000
CY2022	us-gaap	Interest Expense InterestExpense	274000
CY2021	us-gaap	Interest Expense InterestExpense	24608000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-503000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-976000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1276000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-69920000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-103113000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46292000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-495000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3435000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-69425000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-99678000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-46764000
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15584000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-69425000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-99678000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-62348000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.63
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.63
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.23
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.23
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64295000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64295000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61267000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61267000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27950000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27950000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-69425000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-99678000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-46764000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	333000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1178000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1173000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	333000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1178000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1173000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-69092000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-100856000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-45591000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-170664000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	169000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	29020000
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1892000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13486000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18061000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1173000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-46764000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-157580000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10211000
CY2022	inta	Stock Issued During Period Value Vesting Of Early Exercised Stock Options StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions	2214000
CY2022	inta	Share Based Compensation Arrangement By Share Based Payment Award Vesting Of Performance Stock And Restricted Stock Awards Value Net Of Shares Withheld For Taxes ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingOfPerformanceStockAndRestrictedStockAwardsValueNetOfSharesWithheldForTaxes	-3923000
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1163000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	77514000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1178000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-99678000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	255882000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23456000
CY2023	inta	Share Based Compensation Arrangement By Share Based Payment Award Vesting Of Performance Stock And Restricted Stock Awards Value Net Of Shares Withheld For Taxes ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingOfPerformanceStockAndRestrictedStockAwardsValueNetOfSharesWithheldForTaxes	-9056000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2700000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	67769000
CY2023	inta	Stock Issued During Period Value Upon Business Combination StockIssuedDuringPeriodValueUponBusinessCombination	1035000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	333000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-69425000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	341208000
CY2023	us-gaap	Profit Loss ProfitLoss	-69425000
CY2022	us-gaap	Profit Loss ProfitLoss	-99678000
CY2021	us-gaap	Profit Loss ProfitLoss	-46764000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15319000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16742000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13365000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4639000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	922000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	541000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	424000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	67769000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	77514000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	18061000
CY2023	inta	Lease Modification And Impairment LeaseModificationAndImpairment	1601000
CY2022	inta	Lease Modification And Impairment LeaseModificationAndImpairment	0
CY2021	inta	Lease Modification And Impairment LeaseModificationAndImpairment	0
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2407000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2023	inta	Change In Fair Value Of Contingent Consideration Including Unrealized Foreign Exchange Gain ChangeInFairValueOfContingentConsiderationIncludingUnrealizedForeignExchangeGain	-1762000
CY2022	inta	Change In Fair Value Of Contingent Consideration Including Unrealized Foreign Exchange Gain ChangeInFairValueOfContingentConsiderationIncludingUnrealizedForeignExchangeGain	-2776000
CY2021	inta	Change In Fair Value Of Contingent Consideration Including Unrealized Foreign Exchange Gain ChangeInFairValueOfContingentConsiderationIncludingUnrealizedForeignExchangeGain	0
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-912000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4237000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-455000
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-154000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	133000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1155000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	26402000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18205000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	26042000
CY2023	inta	Increase Decrease In Unbilled Receivables Current IncreaseDecreaseInUnbilledReceivablesCurrent	3898000
CY2022	inta	Increase Decrease In Unbilled Receivables Current IncreaseDecreaseInUnbilledReceivablesCurrent	-1347000
CY2021	inta	Increase Decrease In Unbilled Receivables Current IncreaseDecreaseInUnbilledReceivablesCurrent	-1738000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1261000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-905000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4672000
CY2023	inta	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	-3394000
CY2022	inta	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	-7977000
CY2021	inta	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	-3888000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2313000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15589000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10680000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	46565000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	35345000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	28787000
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5922000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1341000
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3148000
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2138000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27487000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14236000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9749000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2212000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	554000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2473000
CY2023	us-gaap	Payments For Software PaymentsForSoftware	5524000
CY2022	us-gaap	Payments For Software PaymentsForSoftware	4233000
CY2021	us-gaap	Payments For Software PaymentsForSoftware	2526000
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	6604000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2500000
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	20605000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14340000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7287000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25604000
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	0
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	278000000
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	5000000
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	70080000
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	292758000
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0
CY2023	inta	Payments For Deferred Offering Costs PaymentsForDeferredOfferingCosts	790000
CY2022	inta	Payments For Deferred Offering Costs PaymentsForDeferredOfferingCosts	4358000
CY2021	inta	Payments For Deferred Offering Costs PaymentsForDeferredOfferingCosts	5410000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	29020000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23456000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10211000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15686000
CY2023	inta	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	2700000
CY2022	inta	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	1163000
CY2021	inta	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	0
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9056000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3923000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	769000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	22290000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	10435000
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0
CY2023	inta	Repurchase Of Shares And Fully Vested Option RepurchaseOfSharesAndFullyVestedOption	0
CY2022	inta	Repurchase Of Shares And Fully Vested Option RepurchaseOfSharesAndFullyVestedOption	0
CY2021	inta	Repurchase Of Shares And Fully Vested Option RepurchaseOfSharesAndFullyVestedOption	1892000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	64100000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6647000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32404000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-373000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-748000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1253000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	76874000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12848000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1696000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54311000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41463000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	43159000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	131185000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54311000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41463000
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	130377000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50783000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37636000
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	808000
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3528000
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3827000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	131185000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54311000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41463000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5950000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	24139000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1812000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	864000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	522000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	517000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	28000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0
CY2023	inta	Capitalized Internal Use Software Costs In Accounts Payable And Accrued Liabilities CapitalizedInternalUseSoftwareCostsInAccountsPayableAndAccruedLiabilities	-378000
CY2022	inta	Capitalized Internal Use Software Costs In Accounts Payable And Accrued Liabilities CapitalizedInternalUseSoftwareCostsInAccountsPayableAndAccruedLiabilities	0
CY2021	inta	Capitalized Internal Use Software Costs In Accounts Payable And Accrued Liabilities CapitalizedInternalUseSoftwareCostsInAccountsPayableAndAccruedLiabilities	0
CY2023	inta	Deferred Offering Costs In Accounts Payable And Accrued Liabilities DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities	776000
CY2022	inta	Deferred Offering Costs In Accounts Payable And Accrued Liabilities DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities	0
CY2021	inta	Deferred Offering Costs In Accounts Payable And Accrued Liabilities DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities	3990000
CY2023	inta	Convertible Preferred Stock Converted To Common Stock Upon Initial Public Offering ConvertiblePreferredStockConvertedToCommonStockUponInitialPublicOffering	0
CY2022	inta	Convertible Preferred Stock Converted To Common Stock Upon Initial Public Offering ConvertiblePreferredStockConvertedToCommonStockUponInitialPublicOffering	144148000
CY2021	inta	Convertible Preferred Stock Converted To Common Stock Upon Initial Public Offering ConvertiblePreferredStockConvertedToCommonStockUponInitialPublicOffering	0
CY2023	inta	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	0
CY2022	inta	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	2214000
CY2021	inta	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	0
CY2023	inta	Deferred Consideration In Other Liabilities DeferredConsiderationInOtherLiabilities	0
CY2022	inta	Deferred Consideration In Other Liabilities DeferredConsiderationInOtherLiabilities	10390000
CY2021	inta	Deferred Consideration In Other Liabilities DeferredConsiderationInOtherLiabilities	0
CY2023	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	1035000
CY2022	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0
CY2023	inta	Acquisition Holdbacks In Other Liabilities AcquisitionHoldbacksInOtherLiabilities	1624000
CY2022	inta	Acquisition Holdbacks In Other Liabilities AcquisitionHoldbacksInOtherLiabilities	1500000
CY2021	inta	Acquisition Holdbacks In Other Liabilities AcquisitionHoldbacksInOtherLiabilities	2126000
CY2023	inta	Fair Value Of Contingent Considerations In Accrued And Other Liabilities FairValueOfContingentConsiderationsInAccruedAndOtherLiabilities	4317000
CY2022	inta	Fair Value Of Contingent Considerations In Accrued And Other Liabilities FairValueOfContingentConsiderationsInAccruedAndOtherLiabilities	4126000
CY2021	inta	Fair Value Of Contingent Considerations In Accrued And Other Liabilities FairValueOfContingentConsiderationsInAccruedAndOtherLiabilities	23502000
CY2023	inta	Non Cash Or Part Noncash Acquisition Cash Paid NonCashOrPartNoncashAcquisitionCashPaid	6711000
CY2022	inta	Non Cash Or Part Noncash Acquisition Cash Paid NonCashOrPartNoncashAcquisitionCashPaid	2500000
CY2021	inta	Non Cash Or Part Noncash Acquisition Cash Paid NonCashOrPartNoncashAcquisitionCashPaid	21925000
CY2023	inta	Non Cash Or Part Noncash Acquisition Cash Acquired NonCashOrPartNoncashAcquisitionCashAcquired	107000
CY2022	inta	Non Cash Or Part Noncash Acquisition Cash Acquired NonCashOrPartNoncashAcquisitionCashAcquired	0
CY2021	inta	Non Cash Or Part Noncash Acquisition Cash Acquired NonCashOrPartNoncashAcquisitionCashAcquired	1320000
CY2023	inta	Non Cash Or Part Noncash Acquisition Consideration NonCashOrPartNoncashAcquisitionConsideration	6604000
CY2022	inta	Non Cash Or Part Noncash Acquisition Consideration NonCashOrPartNoncashAcquisitionConsideration	2500000
CY2021	inta	Non Cash Or Part Noncash Acquisition Consideration NonCashOrPartNoncashAcquisitionConsideration	20605000
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Note 1. Description of Business</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Intapp, Inc. (“Intapp” or the “Company”), formerly known as LegalApp Holdings, Inc., was incorporated in Delaware on November 27, 2012 to facilitate the acquisition of Integration Appliance, Inc. which became a wholly owned subsidiary of Intapp, Inc. on December 21, 2012. LegalApp Holdings, Inc. changed its name to Intapp, Inc. in February 2021. Intapp has no significant assets or operations other than the ownership of Integration Appliance, Inc.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Company is a leading provider of industry-specific, cloud-based software solutions for the global professional and financial services industry. The Company empowers private capital, investment banking, legal, accounting, and consulting firms with the technology they need to meet rapidly changing client, investor, and regulatory requirements, deliver the right insights to the right professionals, replace legacy systems, and operate more competitively. The Company serves clients primarily in the United States, United Kingdom and Australian markets. References to “the Company,” “us,” “we,” or “our” in these consolidated financial statements refer to the consolidated operations of Intapp and its consolidated subsidiaries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Public Offerings</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">On July 2, 2021, the Company completed its Initial Public Offering (“IPO”), in which it sold </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">10,500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of common stock at a public offering price of $</span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">26.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> per share for net proceeds of $</span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">244.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> million after deducting underwriting discounts of $</span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">18.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> million and offering costs of $</span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">9.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> million. </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Upon the closing of the IPO, all outstanding shares of Series A and Series A-1 convertible preferred stock automatically converted into </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">19,034,437</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of common stock on a one-for-one basis</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">On July 8, 2021, the underwriters of the Company’s IPO exercised in full their right to purchase an additional </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">1,575,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of common stock at the public offering price of $</span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">26.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> per share, resulting in additional net proceeds of $</span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">38.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> million after deducting underwriting discounts of $</span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> million.</span></p>
CY2021Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	16965000
CY2023	inta	Capitalized Contract Cost Amount Capitalized CapitalizedContractCostAmountCapitalized	16242000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Those estimates and assumptions include, but are not limited to, revenue recognition including determination of the standalone selling price (“SSP”) of the deliverables included in multiple deliverable revenue arrangements; allowance for doubtful accounts; the depreciable lives of long-lived assets including intangible assets; the expected useful life of deferred commissions; the fair value of stock-based awards; the fair value of assets acquired and liabilities assumed in business combinations; goodwill and long-lived assets impairment assessment; the fair value of contingent consideration liabilities; the incremental borrowing rate used to determine the operating lease liabilities; valuation allowances on deferred tax assets; uncertain tax positions; and loss contingencies. The Company evaluates estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from these estimates, and those differences could be material to the consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023	us-gaap	Advertising Expense AdvertisingExpense	1300000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	1300000
CY2023	inta	Stock Based Compensation Recognized On Straight Line Basis Over Period StockBasedCompensationRecognizedOnStraightLineBasisOverPeriod	P4Y
CY2023	inta	Share Based Compensation Arrangement By Share Based Payment Award Unvested Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedCompensationCost	0
CY2022	inta	Capitalized Contract Cost Amount Capitalized CapitalizedContractCostAmountCapitalized	16929000
CY2023	inta	Capitalized Internal Use Software Estimated Useful Life CapitalizedInternalUseSoftwareEstimatedUsefulLife	P4Y
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1
CY2023Q2	us-gaap	Acquired Finite Lived Intangible Asset Residual Value AcquiredFiniteLivedIntangibleAssetResidualValue	0
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-12848000
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-8952000
CY2023Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	28336000
CY2022Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	24942000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	43257000
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	114231000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	65801000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	48430000
CY2023	inta	Lessee Operating Lease Expiration Year LesseeOperatingLeaseExpirationYear	2030
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk and Significant Clients</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. The Company maintains its cash with multiple high quality financial institutions. The Company is exposed to credit risk for cash held in financial institutions to the extent that such amounts recorded on the balance sheet are in excess of amounts that are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any such losses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> client individually accounted for 10% or more of the Company’s revenues for any of the fiscal years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">June 30, 2023, 2022 and 2021. As of June 30, 2023 and 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> client individually accounted for </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% of the Company’s total accounts receivable, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p>
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	119831000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	76574000
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21300000
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	24700000
CY2022Q3	inta	Prepayments Deferred Rent And Accrued Lease Incentives PrepaymentsDeferredRentAndAccruedLeaseIncentives	3400000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	350873000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	272071000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	214633000
CY2022Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	24942000
CY2023Q2	inta	Unbilled Receivables Current And Noncurrent UnbilledReceivablesCurrentAndNoncurrent	10765000
CY2022Q2	inta	Unbilled Receivables Current And Noncurrent UnbilledReceivablesCurrentAndNoncurrent	6922000
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	192397000
CY2022Q2	us-gaap	Deferred Revenue DeferredRevenue	145480000
CY2023Q2	inta	Unbilled Receivables Noncurrent UnbilledReceivablesNoncurrent	104000
CY2022Q2	inta	Unbilled Receivables Noncurrent UnbilledReceivablesNoncurrent	159000
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	140900000
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	404500000
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.62
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022Q2	us-gaap	Goodwill Goodwill	269103000
CY2021Q2	us-gaap	Goodwill Goodwill	262270000
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	8669000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	7974000
CY2023	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	784000
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	334000
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1141000
CY2023Q2	us-gaap	Goodwill Goodwill	278890000
CY2022Q2	us-gaap	Goodwill Goodwill	269103000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10773000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13519000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10870000
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	10208000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7506000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5090000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4925000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4428000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	6417000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	38574000
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27984000
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19797000
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11618000
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7514000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16366000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12283000
CY2023	us-gaap	Depreciation Depreciation	1600000
CY2022	us-gaap	Depreciation Depreciation	1300000
CY2021	us-gaap	Depreciation Depreciation	1300000
CY2023	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	5900000
CY2022	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	4200000
CY2021	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2500000
CY2023	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2900000
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1900000
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1200000
CY2023Q2	inta	Net Book Value Of Capitalized Software Development Costs NetBookValueOfCapitalizedSoftwareDevelopmentCosts	10300000
CY2022Q2	inta	Net Book Value Of Capitalized Software Development Costs NetBookValueOfCapitalizedSoftwareDevelopmentCosts	7300000
CY2023	inta	Lessee Operating Lease Expiration Year LesseeOperatingLeaseExpirationYear	2030
CY2023Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1600000
CY2023	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	extend the existing leased office space for an additional 12 months through August 2024.
CY2023	inta	Adjustment Of Right Of Use Asset And Lease Liability AdjustmentOfRightOfUseAssetAndLeaseLiability	2500000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	6113000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	843000
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1600000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	9000000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	8400000
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.071
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	7582000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3253000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4700000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5998000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3813000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3420000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2866000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3158000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	6466000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	25721000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4830000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	20891000
CY2023Q2	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	10003000
CY2023Q2	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	2977000
CY2023Q2	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	1527000
CY2023Q2	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	1622000
CY2023Q2	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	1082000
CY2023Q2	us-gaap	Purchase Obligation PurchaseObligation	17211000
CY2023Q2	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	106300000
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2400000
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	all outstanding shares of Series A and Series A-1 convertible preferred stock were automatically converted into 19,034,437 shares of the Company’s common stock on a one-for-one basis.
CY2021Q3	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	19034437
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	67769000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	77514000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18566000
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	83600000
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-246000
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	21194000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14685000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.11
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M18D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	262762000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	104000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	32.22
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1565000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.52
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	451000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	14.95
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12773000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.56
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	65284000
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2313000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.14
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	323000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	18.08
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10137000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.42
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	319250000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9304000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.62
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y3M18D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	300378000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	10137000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.42
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y6M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	319250000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	67800000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	77500000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	18100000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	500000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.009
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.01
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.40
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.38
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-72871000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-104391000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-48063000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2951000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1278000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1771000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-69920000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-103113000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46292000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-48000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	11000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	226000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	278000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	117000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	437000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	572000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	799000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	417000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	802000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	927000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-154000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	137000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-327000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	131000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	17000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-431000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-4505000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-472000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-912000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4237000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-455000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-495000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3435000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-14683000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-21654000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-9721000
CY2023	inta	Income Tax Reconciliation State Tax Net Of Federal Benefit IncomeTaxReconciliationStateTaxNetOfFederalBenefit	192000
CY2022	inta	Income Tax Reconciliation State Tax Net Of Federal Benefit IncomeTaxReconciliationStateTaxNetOfFederalBenefit	140000
CY2021	inta	Income Tax Reconciliation State Tax Net Of Federal Benefit IncomeTaxReconciliationStateTaxNetOfFederalBenefit	329000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1888000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-1019000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	358000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-3311000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	6828000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-314000
CY2023	inta	Income Tax Reconciliation Acquisition Related Transaction Costs IncomeTaxReconciliationAcquisitionRelatedTransactionCosts	254000
CY2022	inta	Income Tax Reconciliation Acquisition Related Transaction Costs IncomeTaxReconciliationAcquisitionRelatedTransactionCosts	53000
CY2021	inta	Income Tax Reconciliation Acquisition Related Transaction Costs IncomeTaxReconciliationAcquisitionRelatedTransactionCosts	1169000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	20764000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10802000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	9360000
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1823000
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-623000
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	7000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-495000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3435000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472000
CY2023Q2	inta	Deferred Tax Assets Nondeductible Accrued Expenses DeferredTaxAssetsNondeductibleAccruedExpenses	2658000
CY2022Q2	inta	Deferred Tax Assets Nondeductible Accrued Expenses DeferredTaxAssetsNondeductibleAccruedExpenses	2039000
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	29054000
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30828000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	6634000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4377000
CY2023Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	22934000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	11079000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	9112000
CY2023Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	14342000
CY2022Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	15827000
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	709000
CY2022Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	487000
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	234000
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	320000
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71911000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	45338000
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15733000
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17652000
CY2022Q2	inta	Deferred Tax Liabilities Revenue Recognition DeferredTaxLiabilitiesRevenueRecognition	2303000
CY2023Q2	inta	Deferred Tax Liabilities Deferred Commissions DeferredTaxLiabilitiesDeferredCommissions	5906000
CY2022Q2	inta	Deferred Tax Liabilities Deferred Commissions DeferredTaxLiabilitiesDeferredCommissions	6207000
CY2023Q2	inta	Deferred Tax Liabilities Fixed Assets DeferredTaxLiabilitiesFixedAssets	2479000
CY2022Q2	inta	Deferred Tax Liabilities Fixed Assets DeferredTaxLiabilitiesFixedAssets	1452000
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	8090000
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	9158000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	16475000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	19120000
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	742000
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1468000
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71900000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	45300000
CY2023Q2	inta	Accumulated Undistributed Earnings Generated By Foreign Subsidiaries AccumulatedUndistributedEarningsGeneratedByForeignSubsidiaries	19800000
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0
CY2023Q2	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0
CY2022Q2	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.63
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.63
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.23
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3811000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2970000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2783000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	532000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	396000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	453000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	968000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	445000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	640000
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5311000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3811000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2970000
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5300000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3800000
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-69425000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-99678000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-46764000
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15584000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-69425000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-99678000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-62348000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64295000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64295000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61267000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61267000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27950000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27950000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.23
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15955000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17262000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	37865000
CY2012Q4	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	1
CY2012Q4	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	1
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3800000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3000000.0
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2400000
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1700000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	900000

Files In Submission

Name	View Source	Status
0000950170-23-047051-index-headers.html	Edgar Link	pending
0000950170-23-047051-index.html	Edgar Link	pending
0000950170-23-047051.txt	Edgar Link	pending
0000950170-23-047051-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img116169085_0.jpg	Edgar Link	pending
img155550217_0.jpg	Edgar Link	pending
img24973531_0.jpg	Edgar Link	pending
inta-20230630.htm	Edgar Link	pending
inta-20230630.xsd	Edgar Link	pending
inta-ex10_26.htm	Edgar Link	pending
inta-ex19_1.htm	Edgar Link	pending
inta-ex21_1.htm	Edgar Link	pending
inta-ex23_1.htm	Edgar Link	pending
inta-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
inta-20230630_lab.xml	Edgar Link	unprocessable
inta-20230630_def.xml	Edgar Link	unprocessable
inta-20230630_pre.xml	Edgar Link	unprocessable
inta-20230630_htm.xml	Edgar Link	completed
inta-ex31_1.htm	Edgar Link	pending
inta-ex31_2.htm	Edgar Link	pending
inta-ex32_1.htm	Edgar Link	pending
inta-ex32_2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INTA
Intapp Inc Stock $inta

2023 Q3 Form 10-K Financial Statement

#000095017023047051 Filed on September 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTA Intapp Inc Stock $inta

2023 Q3 Form 10-K Financial Statement

#000095017023047051 Filed on September 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTA
Intapp Inc Stock $inta